ストックスクリーナーアプリを入手
19.21
3.11%
-0.63
前日終値:
$19.84
開ける：
$19.84
24時間の取引高:
95,167
Relative Volume:
1.03
時価総額：
$1.11B
収益：
-
当期純損益:
$-75.28M
株価収益率:
-9.6257
EPS:
-1.9957
ネットキャッシュフロー:
$-57.45M
1週間 パフォーマンス:
-6.82%
1か月 パフォーマンス:
+0.38%
6か月 パフォーマンス:
-2.57%
1年 パフォーマンス:
+10.16%
1日の値動き範囲:
$19.12
$19.86
1週間の範囲:
$19.12
$21.00
52週間の値動き範囲:
$14.00
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
OCS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.25 | 1.15B | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
451.24 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.82 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
869.11 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.76 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.74 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-27 | 開始されました | Needham | Buy |
| 2023-12-05 | 開始されました | Chardan Capital Markets | Buy |
| 2023-10-05 | 開始されました | Stifel | Buy |
| 2023-06-14 | 開始されました | BofA Securities | Buy |
| 2023-06-12 | 開始されました | H.C. Wainwright | Buy |
| 2023-06-08 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-10 | 開始されました | Pareto | Buy |
| 2023-04-28 | 開始されました | Wedbush | Outperform |
すべてを表示
Oculis Holding Ag (OCS) 最新ニュース
Oculis Holding AG (NASDAQ:OCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
(OCS) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Analyzing ABVC BioPharma (NASDAQ:ABVC) & Oculis (NASDAQ:OCS) - Defense World
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - Yahoo Finance UK
Oculis (NASDAQ:OCS) Trading Down 6%Should You Sell? - MarketBeat
Wall Street Analysts Predict a 106.04% Upside in Oculis Holding AG (OCS): Here's What You Should Know - Zacks Investment Research
Oculis (NASDAQ:OCS) Trading 7% HigherHere's What Happened - MarketBeat
Oculis (Nasdaq: OCS) accelerates Privosegtor into registrational optic neuropathy trials - Stock Titan
Lifesci Capital Weighs in on Oculis FY2025 Earnings - Defense World
Lifesci Capital Forecasts Oculis FY2025 Earnings - MarketBeat
Will Oculis Holding AG stock benefit from commodity prices2025 Volume Leaders & Community Consensus Trade Signals - Newser
Is Oculis Holding’s New Equity Shelf Shaping a More Flexible Capital Strategy for OCS Investors? - simplywall.st
Oculis (NASDAQ:OCS) Coverage Initiated at Lifesci Capital - MarketBeat
How analysts revise price targets for Oculis Holding AG (CR5) stockMarket Movers & Low Drawdown Momentum Ideas - Newser
Why Oculis Holding AG (CR5) stock is upgraded to buyMarket Activity Report & Weekly Chart Analysis and Guides - Newser
How Oculis Holding AG Equity Warrant stock performs in interest rate cycles2025 Winners & Losers & Verified Swing Trading Watchlists - Newser
LifeSci Capital Initiates Coverage of Oculis Holding (OCS) with Outperform Recommendation - Nasdaq
Oculis Holding AG (OCS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Liquidity Mapping Around (OCS) Price Events - news.stocktradersdaily.com
Why Oculis Holding AG stock could benefit from AI revolution2025 Major Catalysts & AI Driven Price Predictions - moha.gov.vn
US Market Recap: Can Oculis Holding AG stock deliver surprise earnings beatJuly 2025 Final Week & Reliable Entry Point Trade Alerts - moha.gov.vn
Can Oculis Holding AG stock deliver surprise earnings beat - BỘ NỘI VỤ
Is Oculis Holding AG Equity Warrant stock positioned well for digital economyTrade Entry Report & Smart Swing Trading Techniques - BỘ NỘI VỤ
How strong is Oculis Holding AG stock balance sheetQuarterly Trade Report & Entry Point Confirmation Signals - BỘ NỘI VỤ
Oculis reports Q3 EPS (32c), consensus (41c) - MSN
Oculis (NASDAQ: OCS) to Run Global PIONEER Privosegtor Trials in AON and NAION - Stock Titan
Analysts Set Oculis Holding AG (NASDAQ:OCS) Target Price at $39.80 - Defense World
Cash per share of Oculis Holding AG – FWB:CR5 - TradingView
Why (OCS) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Will Oculis Holding AG stock keep outperforming rivalsTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Why millennials buy Oculis Holding AG (CR5) stockJuly 2025 Outlook & Stock Portfolio Risk Management - newser.com
Is Oculis Holding AG Equity Warrant stock a good choice for value investorsWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Is Oculis Holding AG Equity Warrant stock oversold or undervaluedJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
What dividend safety score for Oculis Holding AG Equity Warrant stockPrice Action & Expert Curated Trade Ideas - newser.com
Exit strategy if you’re trapped in Oculis Holding AG Equity WarrantQuarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com
Will Oculis Holding AG (CR5) stock hit Wall Street targets2025 Growth vs Value & Real-Time Volume Triggers - newser.com
Can Oculis Holding AG stock sustain market leadershipMarket Growth Report & Community Trade Idea Sharing - newser.com
What moving averages say about Oculis Holding AG2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Will Oculis Holding AG stock deliver shareholder valueQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Why Oculis Holding AG Equity Warrant stock remains resilientEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Oculis Holding AG Equity Warrant stock trend outlook and recovery pathMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
Oculis Holding Ag (OCS) 財務データ
収益
当期純利益
現金流量
EPS
0.40%
0.24%
大文字化:
|
ボリューム (24 時間):